Weight loss medications like Ozempic, Wegovy, and Mounjaro are not only effective in curbing appetite but also in reducing ...

The investment landscape has transformed since the presidential election, with small-cap stocks gaining momentum. The Russell ...

Medically reviewed by Peter Weiss, MD Ozempic is the brand name of a medication called semaglutide, a glucagon-like peptide-1 ...

While surgery has a low risk for complications, when they do occur, they are serious. This may explain why only 5%-10% of ...

About one-third of U.S. adults without diabetes who are eligible for weight loss treatment with glucagon-like peptide 1 (GLP-1) receptor agonists and GLP-1/glucose-dependent insulinotropic polypeptide ...

In a new guidance statement, the American Diabetes Association advises against the use of unapproved products, warning of ...

poll finding that one in eight adult Americans has taken a Glucagon-like peptide-1 (GLP-1), the technical name for ...

We recently compiled a list of the 10 High Growth Healthcare Stocks to Invest in Now. In this article, we are going to take a ...

We recently compiled a list of the 10 High Growth Healthcare Stocks to Invest in Now. In this article, we are going to take a ...

Semaglutide and liraglutide are associated with a reduced risk for hospitalization due to alcohol use disorder (AUD).

GLP-1 receptor agonist use is associated with benefits in a number of different disease and may help treat patients with lupus nephritis.

A study finds that anti-obesity medications may help reduce alcohol consumption, with nearly half of participants in weight ...